XOMA Corp (XOMA)

0.58
0.00 0.47
NASDAQ : Health Care
Prev Close 0.58
Open 0.57
Day Low/High 0.57 / 0.59
52 Wk Low/High 0.44 / 2.03
Volume 408.51K
Avg Volume 1.05M
Exchange NASDAQ
Shares Outstanding 120.58M
Market Cap 69.94M
EPS -0.20
P/E Ratio 29.00
Div & Yield N.A. (N.A)

Latest News

XOMA Initiates XOMA 358 Proof-of-Concept Study In Patients With Hypoglycemia Post Gastric Bypass Surgery

XOMA Initiates XOMA 358 Proof-of-Concept Study In Patients With Hypoglycemia Post Gastric Bypass Surgery

Novel first-in-class antibody enters clinic for second rare hypoglycemic indication

XOMA Presented First Data From Novel Antibody Fragment To Address Severe Acute Hypoglycemia At The ENDO Meeting

XOMA Presented First Data From Novel Antibody Fragment To Address Severe Acute Hypoglycemia At The ENDO Meeting

Data supports continued development of XOMA 129 as a novel targeted therapy for the treatment of hypoglycemic conditions

XOMA (XOMA) Weak On High Volume

XOMA (XOMA) Weak On High Volume

Trade-Ideas LLC identified XOMA (XOMA) as a weak on high relative volume candidate

Xoma Stock Soaring on Q4 Earnings Beat

Xoma Stock Soaring on Q4 Earnings Beat

Xoma stock is gaining on heavy trading volume early Thursday afternoon after the company reported its 2015 fourth quarter results after yesterday’s closing bell.

Xoma Stock Surges in After-Hours Trading on Q4 Results

Xoma Stock Surges in After-Hours Trading on Q4 Results

Xoma stock is jumping in after-hours trading on Wednesday after the company reported its 2015 fourth quarter results.

XOMA Reports Fourth Quarter And Full-Year 2015 Financial Results

XOMA Reports Fourth Quarter And Full-Year 2015 Financial Results

Company Advancing Its Endocrine Portfolio After Completing Divestiture of Non-Core Assets

Xoma Stock Surges, Sells Diabetes Treatment to Novo Nordisk for $295 Million

Xoma Stock Surges, Sells Diabetes Treatment to Novo Nordisk for $295 Million

Xoma stock is rising in early afternoon trading on Tuesday after Novo Nordisk bought its diabetes treatment for $295 million.

Strong On High Volume: XOMA (XOMA)

Strong On High Volume: XOMA (XOMA)

Trade-Ideas LLC identified XOMA (XOMA) as a strong on high relative volume candidate

XOMA Announces The Sale Of Its Manufacturing Facilities To Agenus

XOMA Announces The Sale Of Its Manufacturing Facilities To Agenus

XOMA's divests biodefense program to Nanotherapeutics, Inc.

10 Worst NASDAQ Biotech Stocks in the Third Quarter

10 Worst NASDAQ Biotech Stocks in the Third Quarter

The third quarter was brutal for biotech stocks. Here are the companies that fared the worst.

TRADING ALERT: The Rosen Law Firm Reminds Xoma Corporation Investors Of Important Deadline In Class Action - XOMA

TRADING ALERT: The Rosen Law Firm Reminds Xoma Corporation Investors Of Important Deadline In Class Action - XOMA

The Rosen Law Firm, a global investor rights firm, reminds purchasers of Xoma Corporation (NASDAQ:XOMA) securities during the period from November 6, 2014 through July 21, 2015 of the important September 22, 2015 lead...